Table 5.
Comparison of the occurrence of safety end points in patients treated with and without mild therapeutic hypothermia
| |
Patients undergoing MTH procedure |
Control group |
p |
|---|---|---|---|
| (n = 32) | (n = 33) | ||
| Definite stent thrombosis* |
0 (0%) |
0 (0%) |
ns |
| Probable stent thrombosis* |
0 (0%) |
2 (7.4%) |
ns |
| Pneumonia |
19 (59.4%) |
19 (57.6%) |
ns |
| Positive blood culture |
12 (37.5%) |
11 (33.3%) |
ns |
| Bleeding of any severity |
8 (25.0%) |
5 (15.2%) |
ns |
| Red blood cell transfusion |
4 (12.5%) |
2 (6.1%) |
ns |
| Rhythm and conductions disorders: |
|
|
ns |
| Atrial fibrillation |
6 (18.8%) |
7 (21.2%) |
|
| Ventricular tachycardia |
3 (9.4%) |
1 (3.0%) |
ns |
| Clinically relevant bradycardia | 3 (9.4%) | 1 (3.0%) | ns |
* The percentage refers to the number of patients treated with percutaneous coronary intervention in the group. MTH Mild therapeutic hypothermia.